YUN LING: Open Payments
NPI 1063475341 · AMERICAN FORK, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,126 in 54 payments from 20 companies in 2025. Trend: 2023 $823 · 2024 $1,015 · 2025 $1,126
Food & beverage: $1,126
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $233 |
| Corcept Therapeutics | 7 | $196 |
| Aimmune Therapeutics, Inc. | 4 | $97 |
| Amgen Inc. | 3 | $70 |
| Lilly USA, LLC | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Boston Scientific Corporation | 2 | $42 |
| Medtronic, Inc. | 2 | $41 |
Products named: Korlym, ZENPEP, QULIPTA, VRAYLAR, EVENITY, MOUNJARO, VOQUEZNA, SHINGRIX.
Industry payments across UT — which companies pay providers there.
